Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan

Table 3

Adverse events during EAL-10 and EAL-14 therapies.

Adverse events	EAL-10 (𝑛=100)	EAL-14 (𝑛=100)	𝑃 value
Abdominal pain	5	7	0.552
Constipation	2	2	1.000
Diarrhoea	0	4	0.121
Dizziness	4	1	0.369
Headache	6	3	0.498
Nausea/vomiting	2	2	1.000
Skin rash	0	2	0.497

EAL-10: esomeprazole/amoxicillin/levofloxacin triple therapy × 10 days and EAL-14: esomeprazole/amoxicillin/levofloxacin triple therapy × 14 days.